ScholarIQanswers from OpenAlex & ORCID
Fernando Cabanillas
ResearcherPublications, citations & collaboration network
Fernando Cabanillas is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Fernando Cabanillas have?
ScholarIQindexed works
Fernando Cabanillas has 596 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Fernando Cabanillas have?
ScholarIQcitation count
Fernando Cabanillas has 39,396 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Fernando Cabanillas?
ScholarIQh-index
Fernando Cabanillas has an h-index of 92 in OpenAlex.
What is the i10-index of Fernando Cabanillas?
ScholarIQi10-index
Fernando Cabanillas has an i10-index of 358 in OpenAlex.
What is the ORCID of Fernando Cabanillas?
ScholarIQorcid
The ORCID for Fernando Cabanillas is on the source record.
What is the OpenAlex record for Fernando Cabanillas?
ScholarIQopenalex
The OpenAlex for Fernando Cabanillas is on the source record.
What are the most-cited papers on Fernando Cabanillas?
ScholarIQmost cited works
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
Peter McLaughlin, A.J. Grillo-López, Brian K. Link, Ronald Levy, M. S. Czuczman, Michael E. Williams, Meyer R. Heyman, Isabelle Bence‐Bruckler, Christine A. White, Fernando Cabanillas, Vinay Jain, Anthony D. Ho, John Lister, Ken Wey, Diying Shen, B.K. Dallaire
Non-Hodgkin's Lymphoma in 90 Homosexual Men
John L. Ziegler, Jay A. Beckstead, Paul A. Volberding, Donald I. Abrams, Alexandra M. Levine, Robert J. Lukes, Parkash S. Gill, Ronald L. Burkes, Paul R. Meyer, Craig E. Metroka, Janet Mouradian, A. Holliston Moore, Shirley A. Riggs, James J. Butler, Fernando Cabanillas, Evan M. Hersh, Guy R. Newell, L Laubenstein, Daniel M. Knowles, Chrystia M. Odajnyk, Bruce G. Raphael, Benjamín Koziner, Carlos Urmacher, Bayard D. Glarkson
Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial
Michael Wang, Luis Fayad, Nicolaus A. Wagner‐Bartak, Liang Zhang, Fredrick Hagemeister, Sattva S. Neelapu, Felipe Samaniego, Peter McLaughlin, Michelle A. Fanale, Anas Younes, Fernando Cabanillas, Nathan Fowler, Kate J. Newberry, Luhong Sun, Ken H. Young, Richard E. Champlin, Larry W. Kwak, Lei Feng, Maria Badillo, Maria Teresa Bejarano, Kimberly Hartig, Wendy Chen, Yi‐Ming Chen, Catriona Byrne, Neda Bell, Jerome B. Zeldis, Jorge Romaguera